Skip to content

Nicholas Gregory

4 papers in the library · 19 citations · publishing 2024-2026

Papers

Sort Most recent Most cited

No evidence of immediate or persistent analgesic effect from a single dose of psilocybin in three mouse models of pain

Nature Communications January 22, 2026 Nicholas Gregory, Tyler E. Girard, Akila Ram et al. 5 citations

The psychedelic psilocybin may have lasting therapeutic effects for patients with chronic pain syndromes. Some preclinical data suggest these putative benefits derive from direct analgesic effects; however, this possibility has not been comprehensively tested in preclinical models. Here, we evaluated the analgesic properties of a single exposure to psilocybin at acute and chronic time points in...

Psilocybin has no immediate or persistent analgesic effect in acute and chronic mouse pain models

bioRxiv (Cold Spring Harbor Laboratory) July 7, 2025 Akila Ram, Austen B Casey, Robert C. Malenka et al. 2 citations preprint

Abstract The psychedelic psilocybin may have lasting therapeutic effects for patients with chronic pain syndromes. Some clinical and preclinical data suggest these putative benefits derive from direct analgesic effects. However, this possibility has not been comprehensively tested in preclinical models. Here, we show that psilocybin is not analgesic over a range of doses across multiple pain...

Ketamine evokes acute behavioral effects via μ-opioid receptor expressing neurons of the central amygdala.

Biological Psychiatry May 5, 2025 Matthew B Pomrenze, Sam Vaillancourt, Pierre Llorach et al. 11 citations

Ketamine has anesthetic, analgesic, and antidepressant properties which may involve multiple neuromodulatory systems. In humans, the opioid receptor (OR) antagonist naltrexone blocks the antidepressant effect of ketamine. This mechanism may differentiate ketamine from other NMDA receptor antagonists. Animal models that reflect OR-dependent behavioral effects of ketamine may shed light on the...

Opioid receptor expressing neurons of the central amygdala gate behavioral effects of ketamine in mice.

bioRxiv : the preprint server for biology March 6, 2024 Matthew B Pomrenze, Sam Vaillancourt, Pierre Llorach et al. 1 citation preprint

Ketamine has anesthetic, analgesic, and antidepressant properties which may involve multiple neuromodulatory systems. In humans, the opioid receptor (OR) antagonist naltrexone blocks the antidepressant effect of ketamine. It is unclear whether naltrexone blocks a direct effect of ketamine at ORs, or whether normal functioning of the OR system is required to realize the full antidepressant...